1. Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival.
- Author
-
Zhao Z, Han FH, Yang SB, Hua LX, Wu JH, and Zhan WH
- Subjects
- Adenocarcinoma mortality, Adenocarcinoma pathology, Adenocarcinoma therapy, Adult, Aged, Aged, 80 and over, Chi-Square Distribution, Colorectal Neoplasms mortality, Colorectal Neoplasms pathology, Colorectal Neoplasms therapy, Disease-Free Survival, Down-Regulation, Female, Humans, Immunohistochemistry, Kaplan-Meier Estimate, Male, Middle Aged, Multivariate Analysis, Neoplasm Recurrence, Local, Neoplasm Staging, Proportional Hazards Models, Retrospective Studies, Risk Factors, Stromal Cells metabolism, Time Factors, Young Adult, Adenocarcinoma chemistry, Biomarkers, Tumor analysis, Caveolin 1 analysis, Colorectal Neoplasms chemistry, Stromal Cells chemistry
- Abstract
Aim: To investigate the clinicopathological significance and prognostic value of caveolin-1 (CAV-1) in both tumor and stromal cells in colorectal cancer (CRC)., Methods: A total of 178 patients with CRC were included in this study. The correlation between CAV-1 expression and clinicopathologic features and survival was studied., Results: CAV-1 expression was detected in tumor and stromal cells. The expression of stromal CAV-1 was closely associated with histological type (P=0.022), pathologic tumor-node-metastasis stage (P=0.047), pathologic N stage (P=0.035) and recurrence (P=0.000). However, tumor cell CAV-1 did not show any correlation with clinical parameters. Additionally, the loss of stromal CAV-1 expression was associated with shorter disease-free survival (P=0.000) and overall survival (P=0.000). Multivariate analysis revealed that the loss of stromal CAV-1 expression was an independent prognostic factor for both overall survival (P=0.014) and disease-free survival (P=0.006)., Conclusion: The loss of stromal CAV-1 expression in CRC was associated with poor prognosis and could be a prognostic factor for CRC patients.
- Published
- 2015
- Full Text
- View/download PDF